Yaomin Xu
Last active: 4/6/2017

Yaomin Xu

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Most recent publication(s) are shown below:

  1. Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Luan L, Patil NK, Guo Y, Hernandez A, Bohannon JK, Fensterheim BA, Wang J, Xu Y, Enkhbaatar P, Stark R, Sherwood ER (2017) Sci Rep : 40050
    › Primary publication · 28053314 (PubMed) · PMC5215261 (PubMed Central)
  2. Fulminant Myocarditis with Combination Immune Checkpoint Blockade. Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA, Anders RA, Sosman JA, Moslehi JJ (2016) N Engl J Med 375(18): 1749-1755
    › Primary publication · 27806233 (PubMed) · PMC5247797 (PubMed Central)
  3. Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade. Johnson DB, Frampton GM, Rioth MJ, Yusko E, Xu Y, Guo X, Ennis RC, Fabrizio D, Chalmers ZR, Greenbowe J, Ali SM, Balasubramanian S, Sun JX, He Y, Frederick DT, Puzanov I, Balko JM, Cates JM, Ross JS, Sanders C, Robins H, Shyr Y, Miller VA, Stephens PJ, Sullivan RJ, Sosman JA, Lovly CM (2016) Cancer Immunol Res 4(11): 959-967
    › Primary publication · 27671167 (PubMed) · PMC5134329 (PubMed Central)
  4. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma. Guo X, Xu Y, Zhao Z (2015) Mol Cancer : 60
    › Primary publication · 25890285 (PubMed) · PMC4373107 (PubMed Central)
  5. Snowball: resampling combined with distance-based regression to discover transcriptional consequences of a driver mutation. Xu Y, Guo X, Sun J, Zhao Z (2015) Bioinformatics 31(1): 84-93
    › Primary publication · 25192743 (PubMed) · PMC4271146 (PubMed Central)

Featured Affiliation

No featured affiliations

    View all affiliations

    Contact Information

    No address provided
    615-936-8199 (p)
    Email

    Keywords & MeSH Terms

    MeSH terms are retrieved from PubMed records. Learn more.

    Key: MeSH Term Keyword

    Adjuvants, Immunologic Algorithms Antineoplastic Agents, Immunological B7-H1 Antigen Cell Transformation, Neoplastic Computer Simulation Epigenesis, Genetic Epigenomics Gene Expression Regulation, Neoplastic Genomics Genomics Healthy Volunteers High-Throughput Nucleotide Sequencing Humans Ipilimumab Leukocytes Lipid A Lipopolysaccharides Microarray Analysis Mutation Myocarditis Neoplasms Nivolumab Prognosis Programmed Cell Death 1 Receptor Skin Neoplasms Toll-Like Receptor 4 Transcriptome Transforming Growth Factor beta1 Up-Regulation